Detalles de la búsqueda
1.
Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-451649
2.
Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-429458
3.
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21253098
4.
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21268134
5.
SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-455290
6.
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436864
7.
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-434840
Resultados
1 -
7
de 7
1
Próxima >
>>